IQIRVO
elafibranor
Listed by Ipsen Biopharmaceuticals, Inc.
- Strength
- 80 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Peroxisome Proliferator-activated Receptor Ag…
What it contains
- Elafibranor 80 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Peroxisome Proliferator-activated Receptor Agonist |
| Approval route | NDA — original brand approval |
| NDC code | 15054-0080 |
| FDA application | NDA218860 |
| RxNorm concept | 2684946 |
| Package sizes listed | 1 |
| Marketed since | June 2024 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.